Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents.
about
Aromatase inhibitors in pediatrics.Medical management of adult transsexual persons.Clinical applications of centrally acting agents in male sexual dysfunction.Hypogonadism and renal failure: An update.Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review.Are declining testosterone levels a major risk factor for ill-health in aging men?Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunctionPharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications.Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men.Phase II drugs currently being investigated for the treatment of hypogonadism.Cross-sex hormone therapy for gender dysphoria.Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen.Dr. Casey's Rebuttal.Associations Between Sex Hormone Levels and Periodontitis in Men: Results From NHANES III.Testosterone Pellet Associated Dermatitis: Report and Review of Testopel-related Cutaneous Adverse Effects.Short term testosterone replacement therapy improves libido and body composition.The impact of metabolic syndrome on the responsiveness to α1-blocker in men with BPH/LUTS.A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with
P2860
Q34227175-80B27757-EF2A-4761-8D30-DE4874C0DA3AQ34258902-015071E7-8FB1-4CF7-A524-8C40E7C60B40Q34593179-A12FB690-BCB0-4968-8918-84C82FAAAC37Q35423143-3FA48D7A-C1F4-47BC-9420-CDDBB7E9372AQ37218685-BB1DBD02-7FE2-427C-8DAF-282C5D4912AEQ37335851-7DC03DB0-7BF0-4829-9553-2ACA9EB79320Q37427312-C5714CD0-3B8B-49F3-A21A-C380A600DC5CQ37618221-9D52F713-471E-49DD-823C-D532DFB999E4Q37875669-35EEECE2-C1AB-4055-B5D7-149CD6D09BFCQ37979884-2657146B-D664-4D3B-8556-191AD86F87ABQ38239039-38FB3E9F-8DCE-434F-81DD-614ACBF65D5AQ38268810-DA87643F-6617-415C-870A-1674889D5FD6Q38607545-52103355-5626-49A3-885C-C2A23D538E85Q39020185-5A968C8C-9A45-4F30-8BC3-F8AD35BE1055Q40848557-654FDEBD-D775-47BA-9DFE-57CA979D7EB6Q42375901-523E6D51-BB28-46BA-856D-34CD9643A878Q43176620-0B84D10F-BA7C-40C9-B371-33735AFDB16BQ43574338-28471003-61F5-4037-9A0B-7733673A8976Q48410929-319B531C-ECE9-4659-8AD2-B8EAE4B08C0C
P2860
Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Testosterone replacement thera ...... , and potential future agents.
@ast
Testosterone replacement thera ...... , and potential future agents.
@en
type
label
Testosterone replacement thera ...... , and potential future agents.
@ast
Testosterone replacement thera ...... , and potential future agents.
@en
prefLabel
Testosterone replacement thera ...... , and potential future agents.
@ast
Testosterone replacement thera ...... , and potential future agents.
@en
P2860
P356
P1476
Testosterone replacement thera ...... , and potential future agents.
@en
P2093
P2860
P2888
P356
10.1038/SJ.IJIR.3901366
P577
2005-09-29T00:00:00Z